Billen Daniel's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed May 23, 2023
- Accession no.
- 0001600620-23-000020
- Filed
- May 23, 2023
- Trade date
- May 18-23, 2023
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $52.4K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Billen DanielCIK 0001837593 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | Common Stock | MOption exerciseAcquired | +8,733 | – | – | 28,733 | Direct | |
| May 19, 2023 | Common Stock | AGrant or awardAcquired | +9,310 | $0.00 | $0 | 38,043 | Direct | |
| May 23, 2023 | Common Stock | SSaleDisposed | −4,650 | $11.26 | −$52,359 | 33,393 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | Common Stock | MOption exerciseDisposed | −8,733 | $0.00 | $0 | 0 | Direct | |
| May 19, 2023 | Common Stock | AGrant or awardAcquired | +15,234 | $0.00 | $0 | 15,234 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.